The upward trend since late October is still intact while the swings in price are huge. Volume is still too low. There is a large lot for sale currently at 0.97 before the next price move. We should see continued growth with Q1 results in mid-May.
At the same time, there are key dates for China-US trade talks coming up. The stock tanked last year and my suspicion is it was primarily related to trade and not Kiwa Biotech.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.